A citation-based method for searching scientific literature

Stella Bouziana, Dimitrios Bouzianas. Crit Rev Oncol Hematol 2021
Times Cited: 2







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Tumors driven by RAS signaling harbor a natural vulnerability to oncolytic virus M1.
Jing Cai, Kaiying Lin, Wei Cai, Yuan Lin, Xincheng Liu, Li Guo, Jifu Zhang, Wencang Xu, Ziqing Lin, Chun Wa Wong,[...]. Mol Oncol 2020
4
50

FDA Approval Summary: Nivolumab for the Treatment of Metastatic Non-Small Cell Lung Cancer With Progression On or After Platinum-Based Chemotherapy.
Dickran Kazandjian, Daniel L Suzman, Gideon Blumenthal, Sirisha Mushti, Kun He, Meredith Libeg, Patricia Keegan, Richard Pazdur. Oncologist 2016
240
50

DNA-PK inhibition synergizes with oncolytic virus M1 by inhibiting antiviral response and potentiating DNA damage.
Xiao Xiao, Jiankai Liang, Chunlong Huang, Kai Li, Fan Xing, Wenbo Zhu, Ziqing Lin, Wencang Xu, Guangen Wu, Jifu Zhang,[...]. Nat Commun 2018
22
50

Complete sequence characterization of isolates of Getah virus (genus Alphavirus, family Togaviridae) from China.
You-Gang Zhai, Huan-Yu Wang, Xiao-Hong Sun, Shi-Hong Fu, Huan-Qin Wang, Houssam Attoui, Qing Tang, Guo-Dong Liang. J Gen Virol 2008
45
50

Oncolytic viruses: a new class of immunotherapy drugs.
Howard L Kaufman, Frederick J Kohlhapp, Andrew Zloza. Nat Rev Drug Discov 2015
544
50

Smac mimetics and oncolytic viruses synergize in driving anticancer T-cell responses through complementary mechanisms.
Dae-Sun Kim, Himika Dastidar, Chunfen Zhang, Franz J Zemp, Keith Lau, Matthias Ernst, Andrea Rakic, Saif Sikdar, Jahanara Rajwani, Victor Naumenko,[...]. Nat Commun 2017
35
50

Systematic Characterization of the Biodistribution of the Oncolytic Virus M1.
Jing Cai, Wenbo Zhu, Yuan Lin, Suzhen Zhang, Xueqing Chen, Shoufang Gong, Songmin He, Jun Hu, Guangmei Yan, Jiankai Liang. Hum Gene Ther 2020
4
50

Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods.
J Ferlay, M Colombet, I Soerjomataram, C Mathers, D M Parkin, M Piñeros, A Znaor, F Bray. Int J Cancer 2019
50

Second cancers and causes of death in patients with testicular cancer in Sweden.
Luyao Zhang, Otto Hemminki, Tianhui Chen, Hongyao Yu, Guoqiao Zheng, Subhayan Chattopadhyay, Asta Försti, Kristina Sundquist, Jan Sundquist, Kari Hemminki. PLoS One 2019
10
50

Naturally Existing Oncolytic Virus M1 Is Nonpathogenic for the Nonhuman Primates After Multiple Rounds of Repeated Intravenous Injections.
Haipeng Zhang, Yuan Lin, Kai Li, Jiankai Liang, Xiao Xiao, Jing Cai, Yaqian Tan, Fan Xing, Jialuo Mai, Yuan Li,[...]. Hum Gene Ther 2016
28
50

Targeting VCP enhances anticancer activity of oncolytic virus M1 in hepatocellular carcinoma.
Haipeng Zhang, Kai Li, Yuan Lin, Fan Xing, Xiao Xiao, Jing Cai, Wenbo Zhu, Jiankai Liang, Yaqian Tan, Liwu Fu,[...]. Sci Transl Med 2017
31
50

A classical PKA inhibitor increases the oncolytic effect of M1 virus via activation of exchange protein directly activated by cAMP 1.
Kai Li, Jiankai Liang, Yuan Lin, Haipeng Zhang, Xiao Xiao, Yaqian Tan, Jing Cai, Wenbo Zhu, Fan Xing, Jun Hu,[...]. Oncotarget 2016
17
50

Oncograms Visualize Factors Influencing Long-Term Survival of Cancer Patients Treated with Adenoviral Oncolytic Immunotherapy.
Otto Hemminki, Minna Oksanen, Kristian Taipale, Ilkka Liikanen, Anniina Koski, Timo Joensuu, Anna Kanerva, Akseli Hemminki. Mol Ther Oncolytics 2018
7
50

Identification and characterization of alphavirus M1 as a selective oncolytic virus targeting ZAP-defective human cancers.
Yuan Lin, Haipeng Zhang, Jiankai Liang, Kai Li, Wenbo Zhu, Liwu Fu, Fang Wang, Xiaoke Zheng, Huijuan Shi, Sihan Wu,[...]. Proc Natl Acad Sci U S A 2014
64
50

Oligomerization of the tetramerization domain of p53 probed by two- and three-color single-molecule FRET.
Hoi Sung Chung, Fanjie Meng, Jae-Yeol Kim, Kevin McHale, Irina V Gopich, John M Louis. Proc Natl Acad Sci U S A 2017
31
50

Inhibition of the mevalonate pathway enhances cancer cell oncolysis mediated by M1 virus.
Jiankai Liang, Li Guo, Kai Li, Xiao Xiao, Wenbo Zhu, Xiaoke Zheng, Jun Hu, Haipeng Zhang, Jing Cai, Yaya Yu,[...]. Nat Commun 2018
10
50

Oncolytic virotherapy.
Stephen J Russell, Kah-Whye Peng, John C Bell. Nat Biotechnol 2012
820
50

Effective treatment of an orthotopic xenograft model of human glioblastoma using an EGFR-retargeted oncolytic herpes simplex virus.
Hiroaki Uchida, Marco Marzulli, Kenji Nakano, William F Goins, Janet Chan, Chang-Sook Hong, Lucia Mazzacurati, Ji Young Yoo, Amy Haseley, Hiroshi Nakashima,[...]. Mol Ther 2013
71
50

Intravenous injections of the oncolytic virus M1 as a novel therapy for muscle-invasive bladder cancer.
Cheng Hu, Ying Liu, Yuan Lin, Jian-Kai Liang, Wen-Wen Zhong, Ke Li, Wen-Tao Huang, De-Juan Wang, Guang-Mei Yan, Wen-Bo Zhu,[...]. Cell Death Dis 2018
13
50

Selective Antagonism of Bcl-xL Potentiates M1 Oncolysis by Enhancing Mitochondrial Apoptosis.
Yaqian Tan, Yuan Lin, Kai Li, Xiao Xiao, Jiankai Liang, Jing Cai, Li Guo, Chuntao Li, Wenbo Zhu, Fan Xing,[...]. Hum Gene Ther 2018
10
50

Significance and implications of FDA approval of pembrolizumab for biomarker-defined disease.
Michael M Boyiadzis, John M Kirkwood, John L Marshall, Colin C Pritchard, Nilofer S Azad, James L Gulley. J Immunother Cancer 2018
98
50

Genomic analysis of a Chinese isolate of Getah-like virus and its phylogenetic relationship with other Alphaviruses.
Jin-Sheng Wen, Wen-Zhong Zhao, Jian-Wei Liu, Hong Zhou, Jian-Ping Tao, Hui-Jun Yan, Yu Liang, Jing-Jiao Zhou, Li-Fang Jiang. Virus Genes 2007
26
50


Activation of Cyclic Adenosine Monophosphate Pathway Increases the Sensitivity of Cancer Cells to the Oncolytic Virus M1.
Kai Li, Haipeng Zhang, Jianguang Qiu, Yuan Lin, Jiankai Liang, Xiao Xiao, Liwu Fu, Fang Wang, Jing Cai, Yaqian Tan,[...]. Mol Ther 2016
26
50

Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma.
Robert H I Andtbacka, Howard L Kaufman, Frances Collichio, Thomas Amatruda, Neil Senzer, Jason Chesney, Keith A Delman, Lynn E Spitler, Igor Puzanov, Sanjiv S Agarwala,[...]. J Clin Oncol 2015
50

Intravenous injection of the oncolytic virus M1 awakens antitumor T cells and overcomes resistance to checkpoint blockade.
Yang Liu, Jing Cai, Wenfeng Liu, Yuan Lin, Li Guo, Xincheng Liu, Zhen Qin, Cuiying Xu, Yanming Zhang, Xingwen Su,[...]. Cell Death Dis 2020
10
50


Immune checkpoint blockade and biomarkers of clinical response in non-small cell lung cancer.
Andreas Hallqvist, Anna Rohlin, Sukanya Raghavan. Scand J Immunol 2020
7
50

Anti-CD4 monoclonal antibody treatment of moderate to severe psoriasis vulgaris: results of a pilot, multicenter, multiple-dose, placebo-controlled study.
A B Gottlieb, M Lebwohl, S Shirin, A Sherr, P Gilleaudeau, G Singer, G Solodkina, R Grossman, E Gisoldi, S Phillips,[...]. J Am Acad Dermatol 2000
96
50

Targeting CD4+ Cells with Anti-CD4 Conjugated Mertansine-Loaded Nanogels.
Mine Canakci, Khushboo Singh, Oyuntuya Munkhbat, Sudarvili Shanthalingam, Ankita Mitra, Mallory Gordon, Barbara A Osborne, S Thayumanavan. Biomacromolecules 2020
6
50

The immunopathogenesis and immunotherapy of cutaneous T cell lymphoma: Current and future approaches.
David M Weiner, Joseph S Durgin, Maria Wysocka, Alain H Rook. J Am Acad Dermatol 2021
4
50

In vivo treatment with a monoclonal chimeric anti-CD4 antibody results in prolonged depletion of circulating CD4+ cells in chimpanzees.
M Jonker, W Slingerland, G Treacy, P van Eerd, K Y Pak, E Wilson, S Tam, K Bakker, A F Lobuglio, P Rieber. Clin Exp Immunol 1993
18
50


Phase 1 clinical trial of chimeric monoclonal anti-CD4 antibody in multiple sclerosis.
J W Lindsey, S Hodgkinson, R Mehta, R C Siegel, D J Mitchell, M Lim, C Piercy, T Tram, L Dorfman, D Enzmann. Neurology 1994
53
50

Treatment of multiple sclerosis with the monoclonal anti-CD4 antibody cM-T412: results of a randomized, double-blind, placebo-controlled, MR-monitored phase II trial.
B W van Oosten, M Lai, S Hodgkinson, F Barkhof, D H Miller, I F Moseley, A J Thompson, P Rudge, A McDougall, J G McLeod,[...]. Neurology 1997
184
50

EBV status has prognostic implication among young patients with angioimmunoblastic T-cell lymphoma.
Ahmed E Eladl, Kazuyuki Shimada, Yuka Suzuki, Taishi Takahara, Seiichi Kato, Kei Kohno, Ahmed Ali Elsayed, Chun-Chieh Wu, Takashi Tokunaga, Tomohiro Kinoshita,[...]. Cancer Med 2020
10
50

Enhancing CAR T cell persistence through ICOS and 4-1BB costimulation.
Sonia Guedan, Avery D Posey, Carolyn Shaw, Anna Wing, Tong Da, Prachi R Patel, Shannon E McGettigan, Victoria Casado-Medrano, Omkar U Kawalekar, Mireia Uribe-Herranz,[...]. JCI Insight 2018
219
50

Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias.
Renier J Brentjens, Isabelle Rivière, Jae H Park, Marco L Davila, Xiuyan Wang, Jolanta Stefanski, Clare Taylor, Raymond Yeh, Shirley Bartido, Oriana Borquez-Ojeda,[...]. Blood 2011
849
50

Cutaneous manifestations of adult T-cell leukemia/lymphoma.
Denis Miyashiro, Jose Antonio Sanches. Semin Diagn Pathol 2020
8
50

A herceptin-based chimeric antigen receptor with modified signaling domains leads to enhanced survival of transduced T lymphocytes and antitumor activity.
Yangbing Zhao, Qiong J Wang, Shicheng Yang, James N Kochenderfer, Zhili Zheng, Xiaosong Zhong, Michel Sadelain, Zelig Eshhar, Steven A Rosenberg, Richard A Morgan. J Immunol 2009
207
50


Transgene-enforced co-stimulation of CD4+ T cells leads to enhanced and sustained anti-tumor effector functioning.
L Chang, W C Chang, G McNamara, B Aguilar, J R Ostberg, M C Jensen. Cytotherapy 2007
11
50

Protein L from Peptostreptococcus magnus binds to the kappa light chain variable domain.
B H Nilson, A Solomon, L Björck, B Akerström. J Biol Chem 1992
149
50

CAR T cell immunotherapy for human cancer.
Carl H June, Roddy S O'Connor, Omkar U Kawalekar, Saba Ghassemi, Michael C Milone. Science 2018
920
50

Generation of tumor-infiltrating lymphocyte cultures for use in adoptive transfer therapy for melanoma patients.
Mark E Dudley, John R Wunderlich, Thomas E Shelton, Jos Even, Steven A Rosenberg. J Immunother 2003
446
50

Targeting CTLA-4 in cancer: Is it the ideal companion for PD-1 blockade immunotherapy combinations?
Pushpamali De Silva, Marco Aiello, Chunyan Gu-Trantien, Edoardo Migliori, Karen Willard-Gallo, Cinzia Solinas. Int J Cancer 2021
6
50

Phase I Trial of Fourth-Generation Anti-CD19 Chimeric Antigen Receptor T Cells Against Relapsed or Refractory B Cell Non-Hodgkin Lymphomas.
Xuan Zhou, Sanfang Tu, Chunsheng Wang, Rui Huang, Lan Deng, Chaoyang Song, Chunyan Yue, Yanjie He, Jilong Yang, Zhao Liang,[...]. Front Immunol 2020
4
50

Treatment with Humanized Selective CD19CAR-T Cells Shows Efficacy in Highly Treated B-ALL Patients Who Have Relapsed after Receiving Murine-Based CD19CAR-T Therapies.
Yu Zhao, Zhongfeng Liu, Xuan Wang, Huantong Wu, Jianping Zhang, Junfang Yang, Fayou Zhang, Lining Liu, Jiafu Long, Peihua Lu,[...]. Clin Cancer Res 2019
16
50

Anti-CD1a CAR T cells to selectively target T-ALL.
Paul M Maciocia, Martin A Pule. Blood 2019
4
50

Adoptive-cell-transfer therapy for the treatment of patients with cancer.
Mark E Dudley, Steven A Rosenberg. Nat Rev Cancer 2003
474
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.